| __timestamp | BioCryst Pharmaceuticals, Inc. | ImmunityBio, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 51796000 | 1595000 |
| Thursday, January 1, 2015 | 72758000 | 11434000 |
| Friday, January 1, 2016 | 61008000 | 26546000 |
| Sunday, January 1, 2017 | 66962000 | 39778000 |
| Monday, January 1, 2018 | 84888000 | 53418000 |
| Tuesday, January 1, 2019 | 107068000 | 111997000 |
| Wednesday, January 1, 2020 | 122964000 | 139507000 |
| Friday, January 1, 2021 | 208808000 | 195958000 |
| Saturday, January 1, 2022 | 253297000 | 248149000 |
| Sunday, January 1, 2023 | 216566000 | 232366000 |
In pursuit of knowledge
In the ever-evolving world of biotechnology, research and development (R&D) spending is a key indicator of a company's commitment to innovation. Over the past decade, BioCryst Pharmaceuticals, Inc. and ImmunityBio, Inc. have demonstrated significant investments in R&D, reflecting their dedication to advancing medical science.
From 2014 to 2023, BioCryst Pharmaceuticals increased its R&D spending by approximately 318%, peaking in 2022. ImmunityBio, on the other hand, saw a staggering growth of over 14,500% in the same period, highlighting its aggressive push towards innovation.
By 2023, both companies were investing over $230 million annually in R&D, with ImmunityBio slightly outpacing BioCryst. This trend underscores the competitive nature of the biotech industry, where innovation is not just a goal but a necessity for survival and success.
AstraZeneca PLC vs ImmunityBio, Inc.: Strategic Focus on R&D Spending
Amgen Inc. vs BioCryst Pharmaceuticals, Inc.: Strategic Focus on R&D Spending
Research and Development Investment: argenx SE vs BioCryst Pharmaceuticals, Inc.
Research and Development Investment: Corcept Therapeutics Incorporated vs BioCryst Pharmaceuticals, Inc.
Research and Development Investment: Alpine Immune Sciences, Inc. vs ImmunityBio, Inc.
R&D Spending Showdown: CymaBay Therapeutics, Inc. vs ImmunityBio, Inc.
Research and Development Expenses Breakdown: CRISPR Therapeutics AG vs BioCryst Pharmaceuticals, Inc.
Comparing Innovation Spending: Xenon Pharmaceuticals Inc. and ImmunityBio, Inc.
Comparing Innovation Spending: ImmunityBio, Inc. and Supernus Pharmaceuticals, Inc.
Analyzing R&D Budgets: ImmunityBio, Inc. vs Galapagos NV
Comparing Innovation Spending: Agios Pharmaceuticals, Inc. and BioCryst Pharmaceuticals, Inc.
Who Prioritizes Innovation? R&D Spending Compared for BioCryst Pharmaceuticals, Inc. and Viridian Therapeutics, Inc.